Cite

HARVARD Citation

    Reinisch, W. et al. (2019). Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis. Inflammatory bowel diseases. 25 (4), p. . [Online]. 
  
Back to record